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Objectives. The aim of this retrospective study was to assess the incidence and prevalence of peri-implant mucositis and peri-
implantitis in patients with a fixed full-arch prosthesis supported by two axial and two tilted implants. Materials and Methods.
Sixty-nine patients were included in the study. Each patient received a fixed full-arch prosthesis supported by two mesial axial and
two distal tilted implants to rehabilitate the upper arch, the lower arch, or both.Three hundred thirty-six implants for 84 restorations
were delivered. Patients were scheduled for follow-up visits every 6 months in the first 2 years and yearly after. At each follow-up
visit peri-implant mucositis and peri-implantitis were diagnosed if present. Results. The overall follow-up range was from 12 to 130
months (mean 63,2 months). Three patients presented peri-implantitis. The prevalence of peri-implant mucositis ranged between
0 and 7,14% of patients (5,06% of implants) while the prevalence of peri-implantitis varied from 0 to 4,55% of patients (3,81% of
implants). Conclusions. The prevalence and incidence of peri-implant mucositis and peri-implantitis are lower than most of the
studies in literature. Therefore this kind of rehabilitation could be considered a feasible option, on the condition of adopting a
systematic hygienic protocol.
1. Introduction
Implant therapy is a consolidated procedure for full and
partial rehabilitation of edentulous arches and this waswidely
supported by a large number of prospective studies with long-
term follow-up [1–3].
However, the availability of bone volume could be an
important factor that influences the possibility of achieving
an adequate restoration through implant placement. In fact,
in cases of severe bone atrophy, the available bone may not
be sufficient for implant placement, requiring the adoption
of bone grafting procedures [4]. Even though bone grafting
procedures could be associated with high success rates, as
reported by a number of studies, many complications and
adverse sequelae could occur due to the demanding surgical
procedure [5].
About 10 years ago Malo´ and coworkers [6, 7] described
a treatment procedure that consists in an immediately loaded
full-arch fixed prostheses supported by two mesial axial and
two distal tilted implants, avoiding the adoption of bone
graft procedures in lateroposterior area of mandibular and
maxillary bone. This procedure was validated by scientific
literature in terms of implant survival and success both in
short and medium term, with a comparable bone resorption
between axial and tilted implants [8, 9].
Despite high survival rates of restorations, the abovemen-
tioned surgical technique showed the susceptibility to bio-
logical and technical complications such as veneer fractures,
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soft tissue complications, abutment or screw loosening, loss
of access hole restoration, and loss of retentions which were
frequent [10, 11].
Late biological complications following dental implant
therapy, consisting in peri-implant mucositis and peri-
implantitis, nowadays are receiving increasing interest in the
scientific literature.
Peri-implant mucositis can be described as a reversible
inflammatory reaction of the soft tissues surrounding an
implant whereas peri-implantitis can be identified by inflam-
matory reactions associated with bone loss around the
implant [12].
The 6th and 7th workshops of periodontology suggested
the clinical definition of peri-implant mucositis as the pres-
ence of bleeding on probing without loss of supporting bone.
Peri-implantitis was defined as bleeding on probing, probing
depth > 4mm, and peri-implant bone loss [13, 14].
Heitz-Mayfield and Mombelli in a systematic review in
2014, although the currently available evidence does not allow
any firm specific recommendation for the treatment of peri-
implantitis, stated that some elements of therapy seem to be
beneficial [15]. Those elements are oral hygiene instruction
and counselling for smoking cessation, assessment of the
prosthesis for access for plaque control, prosthesis removal
and adjustments if required, nonsurgical debridement, sur-
gical access to allow cleaning of the contaminated implant,
and stabilization of the intraosseous peri-implant defect with
a bone substitute/bone graft/bioactive substance with or
without barrier membrane [15].
Recent reviews show that there is still lack of literature
about the epidemiology of peri-implant mucositis and peri-
implantitis in different types of rehabilitations, and the high
quality studies presented contrasting results [16–20].
The aim of this retrospective study was to assess the
incidence and prevalence of peri-implant mucositis and peri-
implantitis in immediate full arch rehabilitations supported
by two axial and two tilted implants.
2. Materials and Methods
This retrospective clinical study was conducted according to
the principles embodied in the Helsinki Declaration of 1975
for biomedical research involving human subjects, as revised
in 2000 [21].The research project was approved by the review
board of the IRCCS Istituto Ortopedico Galeazzi (RC 4.73).
2.1. Clinical Chart Selection. Clinical chart of treated patients
were selected on the basis of the following criteria.
(i) The first criterion is patients treated with an imme-
diate loading restoration following the All-on-Four
treatment protocol as described first by Malo´ [6, 7]
and slightly modified by Francetti et al. [22]. Briefly,
firstly conservative and periodontal treatments were
performed. Then all hopeless teeth, if present, were
extracted and a regularization of the edentulous bone
ridge was completed. Four implants (Branemark Sys-
tem MKIV or Nobel-Speedy Groovy, Nobel Biocare,
Zurich, Switzerland) were positioned with the two
anterior axial implants and the distal implants tilted
by approximately 30 degrees with respect to the
occlusal plane. To allow an immediate rehabilitation,
each implant was inserted with a final torque of 40
to 50Ncm. Straight and angulated Multi-Unit Abut-
ments (MUA, Nobel Biocare AB) were connected to
the implants. An impression was taken using a silicon
putty polyvinylsiloxane directly on the coping and
within 48 hours from surgery a temporary prosthesis
was delivered. After 3 months of loading for the lower
arch and 6months of loading for the upper arch, in the
absence of pain and inflammatory signs, the patients
received the definitive prosthesis.
(ii) The second criterion is maxillary or mandibular rest-
oration.
(iii) The third criterion is presence of clinical information
about bleeding index (BI), plaque index (PI) [23], and
probing depth at implant level (PD), retrieved in each
follow-up visit.
(iv) The fourth criterion is presence of periapical radio-
graphs investigating bone resorption rate.
Clinical charts of patients that did not attend even one follow-
up visit were excluded from the study.
2.2. Outcomes. All patients were scheduled for follow-up
visits every 6 months in the first 2 years after surgery and
yearly after.
Each patient received professional oral hygiene treatment
and detailed oral hygiene instructions following the protocol
proposed by Corbella et al. [23].
Oncemedical records includedwere retrieved, the follow-
ing parameters were considered: bleeding index [23], plaque
index [23], and probing depth. Probing depth was measured
using a plastic probe (Color-vue Hu-Friedy, Rotterdam,
Belgium, with University of North Carolina markings) with
a probing force of 0.25N [23]. The prosthesis was removed
during each follow-up in order to access the area to probe.
All radiographs were evaluated.
Incidence and prevalence of biological complications
were the primary outcomes.
An implant was considered affected by peri-implant
mucositis if it had at least one site with bleeding index > 1,
and it was considered affected by peri-implantitis if it had at
least one site with bleeding index > 1, probing depth > 4mm,
and radiographically detectable bone loss.
The related standardized medical records, including
radiographic evaluation of all the surgical and prosthetic
procedures, dental Ct scans, and clinical description that
were included in each case file, were obtained, reviewed, and
analysed by 3 authors independently (NC, SC, and ST). Cases
of disagreement were jointly discussed until an agreement
was achieved.
2.3. Statistical Analysis. Data about prevalence and incidence
of peri-implant mucositis and peri-implantitis were pre-
sented through descriptive statistics. Percentage of implants
and patients affected at a certain follow-up were calculated.
The Scientific World Journal 3
Table 1: Patient-related prevalence in the mandible.
Follow-up𝑁∘ patients 𝑁∘ mucositis (pt) 𝑁∘ peri-implantitis (pt)
6 55 5 (9,09%) 0
12 55 3 (5,45%) 0
18 50 4 (8%) 1 (2%)
24 50 1 (2%) 1 (2%)
36 47 2 (4,26%) 2 (4,26%)
48 42 2 (4,76%) 2 (4,76%)
60 37 3 (8,11%) 2 (5,41%)
72 22 2 (9,09%) 1 (4,55%)
84 18 0 1 (5,56%)
96 7 0 0
108 6 0 0
120 2 0 0
3. Results
An amount of 69 patients (29 male and 40 female patients;
mean age 59,7 years; range from 40 to 84 years) was recruited.
Forty patients received a mandibular restoration, 14 received
a maxillary restoration, and 15 received both.
A total amount of 336 implants was placed (168 axial and
168 tilted) and 84 full arch restorations (55 mandibular and
29 maxillary) were delivered.
Eight mandibular prostheses were supported by Brane-
mark System MKIV implants (Nobel Biocare, Zurich,
Switzerland) (32 implants) while the other 47 mandibular
and 29maxillary prostheses were supported byNobel-Speedy
Groovy implants (Nobel Biocare, Zurich, Switzerland) (304
implants).
Ten patients did not come to all the follow-up visits
expected by this study protocol and were excluded from the
study. They were considered until the last follow-up visit
before being dropped out.
Forty-nine restorations were delivered to nonsmoking
patients, 14 to light-smokers (less than 12 cigarettes/day), and
21 to heavy-smokers (more than 12 cigarettes/day).
The 79,8% of the considered rehabilitations were posi-
tioned in patients with history of periodontitis and the 20,2%
in patients with no history of periodontitis.
The opposing arch of mandibular restorations was a
complete removable denture in the 34,6% of cases, an All-
on-four prosthesis in the 27,3% of cases, teeth with no peri-
odontal disease in the 23,6% of cases, teeth under supportive
periodontal treatment in the 9,1% of cases, a fixed full-arch
prosthesis supported by more than 4 implants in the 3,6% of
cases, and an overdenture in the 1,8% of cases.
Considering maxillary restorations, the opposing arch
was in the 51,7% of cases an All-on-four prosthesis, in the
31,0% of cases teeth with no periodontal disease, and in the
17,3% of cases teeth under supportive periodontal treatment.
The overall follow-up range was from 12 to 130 months
after surgery (mean 63,2 months).
The follow-up range for the mandibular restorations was
from 12 to 130months after surgery (mean 66,7months)while
Table 2: Patient-related prevalence in the maxilla.
Follow-up𝑁∘ patients 𝑁∘ mucositis (pt) 𝑁∘ peri-implantitis (pt)
6 29 1 (3,45%) 0
12 29 0 0
18 28 0 0
24 27 1 (3,70%) 0
36 25 2 (8,00%) 1 (4,00%)
48 17 0 0
60 15 0 0
72 8 0 0
84 4 1 (25,00%) 0
96 2 0 0
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Figure 1: Overall patient-related prevalence of peri-implant mucos-
itis and peri-implantitis.
the follow-up range for themaxillary restorationswas from 12
to 100 months after surgery (mean 56,3 months).
The patient-related prevalence of peri-implant mucositis
and peri-implantitis is shown in Table 1 for mandibular
restoration and in Table 2 for the maxillary ones.
The overall percentage of patient-related prevalence of
peri-implant mucositis and peri-implantitis is shown in
Figure 1. The prevalence of peri-implant mucositis varied
from the 7,14% of patients at 6 months to 0% from 96 to 120
months after surgery, while the prevalence of peri-implantitis
ranged from the 4,55% of patients at 84 months to the 0% at
6, 12, 96, 108, and 120 months after surgery.
The implant-related prevalence of peri-implant mucosi-
tis, peri-implantitis, and implant loss is shown in Table 3 for
mandibular restoration and in Table 4 for the maxillary ones.
The overall percentage of implant-related prevalence of peri-
implant mucositis and peri-implantitis is shown in Figure 2.
It ranged from the 5,06% after 6 months to the 0% after 96,
108, and 120 months from surgery for peri-implant mucositis
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Table 3: Implant-related prevalence in the mandible.
Follow-up 𝑁∘ implants 𝑁∘ mucositis (imp) 𝑁∘ peri-implantitis (imp) Impl. lost
6 220 13 (5,91%) 0 0
12 220 7 (3,18%) 0 0
18 200 7 (3,50%) 1 (0,50%) 0
24 200 4 (2,00%) 1 (0,50%) 0
36 188 2 (1,06%) 2 (1,06%) 0
48 168 2 (1,19%) 5 (2,98%) 0
60 147 3 (2,04%) 4 (2,72%) 1 (0,68%)
72 88 2 (2,27%) 1 (1,14%) 0
84 72 0 3 (4,17%) 0
96 28 0 0 0
108 24 0 0 0
120 8 0 0 0
Table 4: Implant-related prevalence in the maxilla.
Follow-up 𝑁 implants 𝑁
∘ mucositis
(imp)
𝑁
∘ peri-implantitis
(imp)
6 116 4 (3,45%) 0
12 116 0 0
18 112 0 0
24 108 4 (3,70%) 0
36 100 2 (2,00%) 1 (1,00%)
48 68 0 0
60 60 0 0
72 32 0 0
84 16 1 (6,25%) 0
96 8 0 0
and from the 3,81% after 84 months to the 0% after 6, 12, 96,
108, and 120 months from surgery for peri-implantitis.
No significant differences were found between axial and
tilted implants.
The overall implant-related incidence of peri-implant
mucositis, peri-implantitis, and implant loss is shown in
Table 5 and Figure 3.
One implant was lost and recorded at the 60th month
of follow-up. The incidence of peri-implant mucositis was
highest at the 6th month of follow-up with the 5,06% of
implants, while at the 96th, 108th, and 120th month of
follow-up it affected the 0% of them. The incidence of
peri-implantitis ranged from the 2,27% of implants after 84
months to the 0% of implants after 6, 12, 24, 60, 72, 96, 108,
and 120 months of surgery.
The median follow-up time for the incidence of peri-
implantmucositis was 18months and for peri-implantitis was
48 months.
Patient-related and implant-related cumulative rates of
having experienced at least 1 episode of peri-implant mucosi-
tis or peri-implantitis are shown in Tables 6 and 7.
No significant differences were found between smoker
and no-smoker patients.
Implant-related prevalence
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Figure 2: Overall implant-related prevalence of peri-implantmuco-
sitis and peri-implantitis.
Episodes of peri-implantitis were documented in 3 pati-
ents.
All 3 patients had an All-on-Four restoration supported
by Nobel-Speedy Groovy implants.
Patient 1 was a 54-year-old no-smoker woman. She
presented prior history of periodontitis and was under sup-
portive periodontal therapy on the teeth of the opposing jaw.
She was found with one side of a mesial implant with PD =
5mm and a radiographic mild bone loss in the 36 months’
follow-up visit. Episodes of peri-implant mucositis were not
recorded before.
Following amaintenance protocol the situation remained
unchanged until the 84 months’ follow-up visit in which
the peri-implant pocket deepened and peri-implantitis was
diagnosed also in other 2 implants (Figures 4–8).
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Table 5: Incidence of peri-implant mucositis and peri-implantitis.
Follow-up Total implants Incidence mucositis Incidence peri-implantitis Imp. lost
6 336 17 (5,06%) 0 0
12 336 4 (1,19%) 0 0
18 312 4 (1,28%) 1 (0,32%) 0
24 308 8 (2,60%) 0 0
36 288 2 (0,69%) 2 (0,69%) 0
48 236 2 (0,85%) 3 (1,27%) 0
60 207 3 (1,45%) 0 1 (0,48%)
72 120 2 (1,67%) 0 0
84 88 1 (1,14%) 2 (2,27%) 0
96 36 0 0 0
108 24 0 0 0
120 8 0 0 0
Table 6: Patient-related experience of peri-implant mucositis and
peri-implantitis rate.
Follow-up 𝑁 patients Experience ofmucositis
Experience of
peri-implantitis
6 84 6 (7,14%) 0
12 84 8 (9,52%) 0
18 78 10 (12,82%) 1 (1,28%)
24 77 11 (14,29%) 1 (1,30%)
36 72 13 (18,06%) 3 (4,17%)
48 59 15 (25,42%) 2 (3,39%)
60 52 16 (30,77%) 2 (3,85%)
72 30 11 (36,67%) 1 (3,33%)
84 22 10 (45,45%) 1 (4,55%)
96 9 5 (55,56%) 0
108 6 3 (50,00%) 0
120 2 1 (50,00%) 0
Patient 2 was a heavy smoking 62-year-old male. He had
prior history of periodontitis and on the opposing jaw he had
a complete removable denture. At the 18 months’ follow-up
visit he was found with 3 sides of a mesial implant with PD
of 8, 7, and 5mm, a radiographic bone loss, and peri-implant
mucositis in the adjacent implant. Episodes of peri-implant
mucositis were not recorded before. At the 24months’ follow-
up visit the PD of the implant affected by peri-implantitis had
still 2 sides with PD of 7mm and 5mm and after 36 months
only one side with PD of 5mm while the other implants
were healthy. At the 48 months’ follow-up all implants were
diagnosed with peri-implantitis and at the 58th month one
mesial implant was lost due to peri-implantitis.
Patient 3 was a 54-year-old heavy smoking woman.
She had previous history of periodontitis and was under
supportive periodontal therapy on the teeth of opposing arch.
At the 36 months’ follow-up visit she was found with all
sides of a tilted implant with PD between 5mm and 9mm
Table 7: Implant-related experience of peri-implant mucositis and
peri-implantitis rate.
Follow-up 𝑁 implants Experience ofmucositis
Experience of
peri-implantitis
6 336 17 (5,06%) 0
12 336 21 (6,25%) 0
18 312 21 (6,73%) 1 (0,32%)
24 308 28 (9,09%) 1 (0,32%)
36 288 30 (10,42%) 3 (1,04%)
48 236 32 (13,56%) 5 (2,12%)
60 207 30 (14,49%) 5 (2,42%)
72 120 16 (13,33%) 1 (0,83%)
84 88 13 (14,77%) 3 (3,41%)
96 36 5 (13,89%) 0
108 24 3 (12,50%) 0
120 8 1 (12,50%) 0
a radiographic bone loss. Episodes of peri-implant mucositis
were not recorded before.
4. Discussion
Many experiments in animals and studies in humans showed
that plaque formation at implant level resulted in peri-
implant mucositis [24–26].
In the present study the patient-related prevalence of
mucositis was lower than the 8% in any follow-up visit
and it was higher in the first follow-up visit (6 months)
than in the following ones. These findings are in agreement
with O¨stman et al. [27] but in disagreement with several
studies that observed a frequency remarkably higher of peri-
implant mucositis around the 80% of patients [19, 28–33].
These studies examined a great variability of rehabilitations
and implants and reported the bleeding of probing alone as
presence of the pathology. However the bleeding on probing
on its own could overestimate the presence of gingival
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Figure 3: Implant related prevalence and incidence of peri-implant
mucositis, peri-implantitis, and implants’ loss.
Figure 4: Orthopantomography of the patient 6 months after sur-
gery.
Figure 5: Orthopantomography of the patient after 36months from
surgery.
inflammation in periodontally healthy subjects [34]; it could
be strongly influenced by the operator and could lead to a
high rate of false positive values [19]. For this reason in the
present study an implant was considered affected by peri-
implant mucositis if the bleeding score was >1 as indicated
in other studies [23].
The fact that the prosthesis is screw-retained nullifies
the risk of infection due to submucosal persistence of luting
cement [35].
Mombelli et al. [19] based on the reviewed articles stated
that the prevalence of peri-implantitis seemed to be around
the 10%of implants and the 20%of patients during 5–10 years.
However this statement had to be taken with caution
because of the lack of uniformity in the definition, thresholds
Figure 6: Orthopantomography of the patient after 84months from
surgery.
Figure 7: Clinical probing of the peri-implant pockets.
Figure 8: Surgical access to the peri-implant bone defects.
for peri-implantitis, and differences in the composition of the
population among the epidemiological and risk factor studies
as pointed out by several reviews [18–20, 29].
In the present study however the prevalence of peri-
implantitis was lower than 4,5% relating to patients and lower
than 3,5% related to implants.
Moreover all patients that developed peri-implantitis
were not diagnosed with peri-implant mucositis in the
previous follow-up visit.This could suggest that a visit every 6
months in the first 2 years and yearly after may be not enough
frequent to prevent it properly.
By choosing such a generous definition of peri-implantitis
in the first 24 months it could be possible to see some
alterations that include bone loss related to re-establishment
of biologic width. It seems more feasible that signs of peri-
implantitis might not really begin to show until the 36
months’ follow-up or later.
Peri-implantitis did not regress in any patient or implant.
The absence of peri-implantitis in the latest follow-up visits
is due to the limited number of patients that reached the 96,
108, and 120 months’ of follow-up by now.
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This study is not in accordance with Marrone et al. [36]
who in a survey over 133 patients found a strong association
between peri-implant disease and total edentulism, but the
population considered in that survey was very small, only 7
totally edentulous subjects.
In the present study all patients that developed peri-
implantitis had a prior history of periodontitis. This is in
accordance with many previous studies [18, 19, 29, 37, 38]
even if the sample size was limited and the groups of
patients with and without history of periodontitis were not
homogeneous.
Most of the studies concerning risk factors of peri-imp-
lant disease concluded that smoking was distinctly involved
[39–42]. However the present study did not find such an
association even though 2 of the 3 patients that presented
peri-implantitis were heavy smokers. This discrepancy from
literature could be explained either by the small sample size
or by smoking that could have masked symptoms of peri-
implantmucositis reducing vascularization of soft tissues and
the bleeding on probing.
5. Conclusions
The use of immediate loaded full-arch prosthesis supported
by two mesial axial implants and two distal tilted implants
is a viable rehabilitation option, considering the lower rate
of peri-implant mucositis and peri-implantitis compared to
what was found in literature.
However a meticulous attention to the hygienic condi-
tions and the adoption of a systematic follow-up schedule are
necessary.
Further long-term studies are needed in order to achieve a
better understanding of risk factors for peri-implant mucosi-
tis and peri-implantitis and validate effective preventive and
therapeutic protocols.
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